Omnivium Pharmaceuticals LLC – Trademark Portfolio

Entity Type: 16

Omnivium Pharmaceuticals LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include NUMBRINO and OMNIVIUM PHARMACEUTICALS. The owner is based in Rahway, NJ.

2131 Felver Court, Suite A

Rahway, NJ 07065

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Omnivium Pharmaceuticals LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Omnivium Pharmaceuticals LLC have?

Omnivium Pharmaceuticals LLC has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.

What trademark classes does Omnivium Pharmaceuticals LLC file in?

Omnivium Pharmaceuticals LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Omnivium Pharmaceuticals LLC's most well-known trademarks?

Omnivium Pharmaceuticals LLC's registered trademark portfolio includes well-known marks such as NUMBRINO and OMNIVIUM PHARMACEUTICALS. These are among 3 currently registered trademarks in the portfolio.

What is Omnivium Pharmaceuticals LLC's trademark registration success rate?

Omnivium Pharmaceuticals LLC has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.